<!DOCTYPE html>
<html>
<head>
    <title>Chi&#xAD;nese maker of Covid-19 vaccine gets $669m shot in the arm - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201208/281771336767753" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>Chi&#xAD;nese maker of Covid-19 vaccine gets $669m shot in the arm</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201208/textview" title="The Straits Times - 2020-12-08"><time>2020-12-08</time></a>
        - <span>WORLD</span>
        - <span role="byline"></span>
    </section>

    <p>BEI­JING • One of China’s big­gest generic drug mak­ers is in­vest­ing around US$500 mil­lion (S$669 mil­lion) to fund re­search and work on a front run­ner coro­n­avirus vaccine from Si­no­vac Biotech that could be weeks away from be­ing ad­min­is­tered across the world.</p>
    <p>Sino Bio­phar­ma­ceu­ti­cal will buy a 15 per cent stake in a Si­no­vac unit called Si­no­vac Life Sciences, the Bei­jing-based vaccine maker said in a state­ment posted on its web­site yes­ter­day. The in­vest­ment comes as Si­no­vac starts ship­ping its Coron­aVac shot to var­i­ous coun­tries in prepa­ra­tion for mass in­oc­u­la­tion ef­forts.</p>
    <p>The Chi­nese com­pany is ex­pected to re­lease data from fi­nal stage test­ing within days that will show how ef­fec­tive the vaccine is.</p>
    <p>Si­no­vac said it would use the fund­ing for “fur­ther de­vel­op­ment, ca­pac­ity ex­pan­sion and man­u­fac­tur­ing” of its vaccine.</p>
    <p>It added that it aims to pro­duce 300 mil­lion doses of Coron­aVac an­nu­ally and is near­ing com­ple­tion of a sec­ond fac­tory that will dou­ble its pro­duc­tion ca­pac­ity.</p>
    <p>In ad­di­tion to sup­ply­ing the shot in China, the com­pany will need to ship the vaccine ei­ther in bulk or in vials to coun­tries in­clud­ing In­done­sia, Tur­key and Brazil.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
